Tailored Assessment Strategies

We use a breadth of commercial and non-commercial in vitro cell/tissue models spanning from the nasal to alveolar regions. As well as offering standard endpoints for in vitro toxicity (e.g. viability), we work alongside our clients to provide a range of relevant biochemical, morphological and functional assessments for toxicology and pharmacology to meet discovery and early product development needs.  

• Proof of concept studies 
• International collaborative projects